Pain is a complex physiological and psychological phenomenon that is subjective in nature. Pain is still one of the most ...

Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage effectively with existing ...

Background Best current estimates of neuropathic pain (NeuP) prevalence come from studies using various screening detecting pain with probable neuropathic features; the proportion experiencing ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...

Women may experience more chronic pain due to differences in their immune responses and higher levels of leptin. This ...

Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage effectively with existing medications. As a possible alternative treatment option, scientists at ...

Urcosimod stable in single-use ampoules for more than 2½ years FDA requires drug to show long-term shelf stability for ...

Arialief frames nerve pain as a multi-faceted problem: nerve cells are inflamed, starved of nutrients, and sending faulty ...

This important clinical milestone follows compelling preclinical data, where Ketamir-2 demonstrated superior efficacy compared to FDA-approved neuropathic pain treatments, including pregabalin and ...